USA: Navacaprant, a new once-daily kappa opioid receptor antagonist, may cause a significant reduction of depression and anhedonia symptoms in participants with moderate-to-severe major depressive.
Efficacy of novel drug proven in MDD study europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
With some prescription medications, the treatment can be more fatal than the underlying disease, as depression and even suicidal thoughts are listed as potentiside effects for a "variety" of these drugs, experts said.
With some prescription medications, the treatment can be more fatal than the underlying disease, as depression and even suicidal thoughts are listed as potentiside effects for a "variety" of these drugs, experts said.